Increased IL-33 and IL-17 in Colorectal Carcinoma Patients with Severe Disease

Colorectal cancer (CRC) represents one of the most common cancers. It is frequently diagnosed at advanced stages, indicating on need for new diagnostic markers. The aim of this study was to determine systemic and fecal values of IL-17 and IL-33 in patients with CRC and the relationship with clinicop...

Full description

Bibliographic Details
Main Authors: Maric Veljko, Jovanovic Milan, Zdravkovic Natasa, Jovanovic Marina, Gajovic Nevena, Jurisevic Milena, Jovanovic Ivan
Format: Article
Language:English
Published: Sciendo 2020-09-01
Series:Serbian Journal of Experimental and Clinical Research
Subjects:
Online Access:https://doi.org/10.2478/sjecr-2018-0034
id doaj-e2bfa27d37a34908b065028095376d5a
record_format Article
spelling doaj-e2bfa27d37a34908b065028095376d5a2021-09-05T14:01:57ZengSciendoSerbian Journal of Experimental and Clinical Research 1820-86652335-075X2020-09-0121323924510.2478/sjecr-2018-0034Increased IL-33 and IL-17 in Colorectal Carcinoma Patients with Severe DiseaseMaric Veljko0Jovanovic Milan1Zdravkovic Natasa2Jovanovic Marina3Gajovic Nevena4Jurisevic Milena5Jovanovic Marina6Jovanovic Ivan7University of East Sarajevo, Faculty of Medicine Foca, Department of Surgery, Bosnia and HerzegovinaMilitary Medical Academy, Department of Abdominal Surgery, Belgrade, SerbiaUniversity of Kragujevac, Faculty of Medical Sciences, Department of Internal medicine, SerbiaUniversity of Kragujevac, Faculty of Medical Sciences, Department of Internal medicine, SerbiaUniversity of Kragujevac, Faculty of Medical Sciences, Center for Molecular Medicine and Stem Cell Research, SerbiaDepartment of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, SerbiaUniversity of Kragujevac, Faculty of Medical Sciences, Center for Molecular Medicine and Stem Cell Research, SerbiaUniversity of Kragujevac, Faculty of Medical Sciences, Center for Molecular Medicine and Stem Cell Research, SerbiaColorectal cancer (CRC) represents one of the most common cancers. It is frequently diagnosed at advanced stages, indicating on need for new diagnostic markers. The aim of this study was to determine systemic and fecal values of IL-17 and IL-33 in patients with CRC and the relationship with clinicopathological aspects of disease.https://doi.org/10.2478/sjecr-2018-0034colorectal carcinomail-17il-33
collection DOAJ
language English
format Article
sources DOAJ
author Maric Veljko
Jovanovic Milan
Zdravkovic Natasa
Jovanovic Marina
Gajovic Nevena
Jurisevic Milena
Jovanovic Marina
Jovanovic Ivan
spellingShingle Maric Veljko
Jovanovic Milan
Zdravkovic Natasa
Jovanovic Marina
Gajovic Nevena
Jurisevic Milena
Jovanovic Marina
Jovanovic Ivan
Increased IL-33 and IL-17 in Colorectal Carcinoma Patients with Severe Disease
Serbian Journal of Experimental and Clinical Research
colorectal carcinoma
il-17
il-33
author_facet Maric Veljko
Jovanovic Milan
Zdravkovic Natasa
Jovanovic Marina
Gajovic Nevena
Jurisevic Milena
Jovanovic Marina
Jovanovic Ivan
author_sort Maric Veljko
title Increased IL-33 and IL-17 in Colorectal Carcinoma Patients with Severe Disease
title_short Increased IL-33 and IL-17 in Colorectal Carcinoma Patients with Severe Disease
title_full Increased IL-33 and IL-17 in Colorectal Carcinoma Patients with Severe Disease
title_fullStr Increased IL-33 and IL-17 in Colorectal Carcinoma Patients with Severe Disease
title_full_unstemmed Increased IL-33 and IL-17 in Colorectal Carcinoma Patients with Severe Disease
title_sort increased il-33 and il-17 in colorectal carcinoma patients with severe disease
publisher Sciendo
series Serbian Journal of Experimental and Clinical Research
issn 1820-8665
2335-075X
publishDate 2020-09-01
description Colorectal cancer (CRC) represents one of the most common cancers. It is frequently diagnosed at advanced stages, indicating on need for new diagnostic markers. The aim of this study was to determine systemic and fecal values of IL-17 and IL-33 in patients with CRC and the relationship with clinicopathological aspects of disease.
topic colorectal carcinoma
il-17
il-33
url https://doi.org/10.2478/sjecr-2018-0034
work_keys_str_mv AT maricveljko increasedil33andil17incolorectalcarcinomapatientswithseveredisease
AT jovanovicmilan increasedil33andil17incolorectalcarcinomapatientswithseveredisease
AT zdravkovicnatasa increasedil33andil17incolorectalcarcinomapatientswithseveredisease
AT jovanovicmarina increasedil33andil17incolorectalcarcinomapatientswithseveredisease
AT gajovicnevena increasedil33andil17incolorectalcarcinomapatientswithseveredisease
AT jurisevicmilena increasedil33andil17incolorectalcarcinomapatientswithseveredisease
AT jovanovicmarina increasedil33andil17incolorectalcarcinomapatientswithseveredisease
AT jovanovicivan increasedil33andil17incolorectalcarcinomapatientswithseveredisease
_version_ 1717809359689351168